Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Abstract 416: Atorvastatin Versus Placebo In Icu Patients With Covid19: Ninety-day Results Of The INSPIRATION-S Trial
Azita H. Talasaz, Parham Sadeghipour, Babak Sharif-Kashani, Farid Rashidi, Mohammad Taghi Beigmohammadi, Keivan Gohari Moghadam, Somayeh Rezaian, Ali Dabbagh, Seyed Hashem Sezavar, Gregory Piazza, Mohsen Farrokhpour, Hooman Bakhshandeh, Atefeh Abedini, Rasoul Aliannejad, Taghi Riahi, Mahdi Yadollahzadeh, Somayeh Lookzadeh, Parisa Rezaeifar, Samira Matin, Ouria Tahamtan, Keyhan Mohammadi, Elnaz Zoghi, Hossein Mirshojaeian Hosseini, Seyed Masoud Mousavian, Homa Abri, Parham Sadeghipour, Elahe Baghizadeh, Farnaz Rafiee, Sepehr Jamalkhani, Maryam Aghakouchakzadeh, Vahid Eslami, Pooya Payandemehr, David Jiménez, Sanjum S. Sethi, Sahil A. Parikh, Manuel Monréal, Majid Maleki, Majid Maleki, Saeed Sadeghian, Stefano Barco, Bob Siegerink, Gregory Piazza, Ajay J. Kirtane, Benjamín Van Tassell, Gregg W. Stone, Frederikus A. Klok, Professor Gregory Lip, Samuel Z. Goldhaber, Harlan M. Krumholz, Behnood Bikdeli (2023). Abstract 416: Atorvastatin Versus Placebo In Icu Patients With Covid19: Ninety-day Results Of The INSPIRATION-S Trial. , 43(Suppl_1), DOI: https://doi.org/10.1161/atvb.43.suppl_1.416.
Article26 days agoAtorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial
Azita H. Talasaz, Parham Sadeghipour, Hooman Bakhshandeh, Babak Sharif-Kashani, Farid Rashidi, Mohammad Taghi Beigmohammadi, Keivan Gohari Moghadam, Somaye Rezaian, Ali Dabbagh, Seyed Hashem Sezavar, Mohsen Farrokhpour, Atefeh Abedini, Rasoul Aliannejad, Taghi Riahi, Mahdi Yadollahzadeh, Somayeh Lookzadeh, Parisa Rezaeifar, Samira Matin, Ouria Tahamtan, Keyhan Mohammadi, Elnaz Zoghi, Hamid Rahmani, Seyed Hossein Hosseini, Seyed Masoud Mousavian, Homa Abri, Parham Sadeghipour, Elahe Baghizadeh, Farnaz Rafiee, Sepehr Jamalkhani, Ahmad Amin, Bahram Mohebbi, Seyed Ehsan Parhizgar, Mahshid Soleimanzadeh, Maryam Aghakouchakzadeh, Vahid Eslami, Pooya Payandemehr, Hossein Khalili, Hamed Talakoob, Taranom Tojari, Shadi Shafaghi, Sanaz Hariri Tabrizi, Hessam Kakavand, Alireza Kashefizadeh, Atabak Najafi, David Jiménez, Aakriti Gupta, Mahesh V. Madhavan, Sanjum S. Sethi, Sahil A. Parikh, Manuel Monréal, Naser Hadavand, Alireza Hajighasemi, Khalil Ansarin, Majid Maleki, Saeed Sadeghian, Stefano Barco, Bob Siegerink, Erica S. Spatz, Gregory Piazza, Ajay J. Kirtane, Benjamín Van Tassell, Professor Gregory Lip, Frederikus A. Klok, Samuel Z. Goldhaber, Gregg W. Stone, Harlan M. Krumholz, Behnood Bikdeli (2023). Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial. , 123(07), DOI: https://doi.org/10.1055/a-2059-4844.
Article26 days agoIntermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial
Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi, Hooman Bakhshandeh, Farnaz Rafiee, Parisa Rezaeifar, Elahe Baghizadeh, Samira Matin, Sepehr Jamalkhani, Ouria Tahamtan, Babak Sharif-Kashani, Mohammad Taghi Beigmohammadi, Mohsen Farrokhpour, Seyed Hashem Sezavar, Pooya Payandemehr, Ali Dabbagh, Keivan Gohari Moghadam, Hossein Khalili, Mahdi Yadollahzadeh, Taghi Riahi, Atefeh Abedini, Somayeh Lookzadeh, Hamid Rahmani, Elnaz Zoghi, Keyhan Mohammadi, Parham Sadeghipour, Homa Abri, Sanaz Hariri Tabrizi, Seyed Masoud Mousavian, Shaghayegh Shahmirzaei, Ahmad Amin, Bahram Mohebbi, Seyed Ehsan Parhizgar, Rasoul Aliannejad, Vahid Eslami, Alireza Kashefizadeh, Paul P. Dobesh, Hessam Kakavand, Seyed Hossein Hosseini, Shadi Shafaghi, Samrand Fattah Ghazi, Atabak Najafi, David Jiménez, Aakriti Gupta, Mahesh V. Madhavan, Sanjum S. Sethi, Sahil A. Parikh, Manuel Monréal, Naser Hadavand, Alireza Hajighasemi, Majid Maleki, Saeed Sadeghian, Gregory Piazza, Ajay J. Kirtane, Benjamín Van Tassell, Gregg W. Stone, Professor Gregory Lip, Harlan M. Krumholz, Samuel Z. Goldhaber, Parham Sadeghipour (2021). Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial. , 122(01), DOI: https://doi.org/10.1055/a-1485-2372.
Article26 days agoIntermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies
Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi, Babak Sharif-Kashani, Mohsen Farrokhpour, Hooman Bakhshandeh, Seyed Hashem Sezavar, Ali Dabbagh, Mohammad Taghi Beigmohammadi, Pooya Payandemehr, Mahdi Yadollahzadeh, Taghi Riahi, Hossein Khalili, Sepehr Jamalkhani, Parisa Rezaeifar, Atefeh Abedini, Somayeh Lookzadeh, Shaghayegh Shahmirzaei, Ouria Tahamtan, Samira Matin, Ahmad Amin, Seyed Ehsan Parhizgar, David Jiménez, Aakriti Gupta, Mahesh V. Madhavan, Sahil A. Parikh, Manuel Monréal, Naser Hadavand, Alireza Hajighasemi, Majid Maleki, Saeed Sadeghian, Bahram Mohebbi, Gregory Piazza, Ajay J. Kirtane, Professor Gregory Lip, Harlan M. Krumholz, Samuel Z. Goldhaber, Parham Sadeghipour (2020). Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies. , 196, DOI: https://doi.org/10.1016/j.thromres.2020.09.027.
Article26 days agoEffect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit
Saeideh Mazloomzadeh, Shiva Khaleghparast, Behshid Ghadrdoost, Mostafa Mousavizadeh, Mohammad Reza Baay, Feridoun Noohi, Hamidreza Sharifnia, Catherine Vandewaeter, Sasan Tavan, Nasser Malekpour Alamdari, Mohammad Fathi, Mahshid Soleimanzadeh, Mostafa Mostafa, Navid Davoody, Maryam Zarinsadaf, Sara Tayyebi, Fahimeh Farrokhzadeh, Faeze Nezamabadi, Esmaeil Soomari, Parham Sadeghipour, Azita H. Talasaz, Farid Rashidi, Babak Sharif-Kashani, Mohammad Taghi Beigmohammadi, Mohsen Farrokhpour, Seyed Hashem Sezavar, Pooya Payandemehr, Ali Dabbagh, Keivan Gohari Moghadam, Sepehr Jamalkhani, Hossein Khalili, Mahdi Yadollahzadeh, Taghi Riahi, Parisa Rezaeifar, Ouria Tahamtan, Samira Matin, Atefeh Abedini, Somayeh Lookzadeh, Hamid Rahmani, Elnaz Zoghi, Keyhan Mohammadi, Parham Sadeghipour, Homa Abri, Sanaz Hariri Tabrizi, Seyed Masoud Mousavian, Shaghayegh Shahmirzaei, Hooman Bakhshandeh, Ahmad Amin, Farnaz Rafiee, Elahe Baghizadeh, Bahram Mohebbi, Seyed Ehsan Parhizgar, Rasoul Aliannejad, Vahid Eslami, Alireza Kashefizadeh, Hessam Kakavand, Seyed Hossein Hosseini, Shadi Shafaghi, Samrand Fattah Ghazi, Atabak Najafi, David Jiménez, Aakriti Gupta, Mahesh V. Madhavan, Sanjum S. Sethi, Sahil A. Parikh, Manuel Monréal, Naser Hadavand, Alireza Hajighasemi, Majid Maleki, Saeed Sadeghian, Gregory Piazza, Ajay J. Kirtane, Benjamín Van Tassell, Paul P. Dobesh, Gregg W. Stone, Professor Gregory Lip, Harlan M. Krumholz, Samuel Z. Goldhaber, Behnood Bikdeli (2021). Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit. , 325(16), DOI: https://doi.org/10.1001/jama.2021.4152.
Article26 days ago